Key result
LVAD combined with cryoballoon ablation shows no VT recurrence or new arrhythmias at 1 year.
Why the study?
Management of recurrent ventricular tachycardia in patients with dilated cardiomyopathy requiring LVAD implantation remains challenging and innovative combined approaches are needed.
Does LVAD implantation combined with cryoballoon ablation prevent VT recurrence in a patient with dilated cardiomyopathy and recurrent VT?
Case Report (n=1)
No
Does LVAD implantation combined with cryoballoon ablation prevent VT recurrence in a patient with dilated cardiomyopathy and recurrent VT?
Combining LVAD implantation with cryoballoon ablation of VT targets and the surgical incision site successfully prevented VT recurrence at 1 year in a patient with dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in dilated cardiomyopathy; leaves open whether combined LVAD and cryoballoon ablation prevents VT recurrence.
We report a case of a patient with dilated cardiomyopathy who experienced recurrent ventricular tachycardia (VT) and multiple defibrillations following CRT-D implantation. Due to worsening cardiac function, the patient required surgical implantation of a left ventricular assist device (LVAD) as a bridge to heart transplantation. During the procedure, we used the Ensite three-dimensional mapping system to perform activation and substrate mapping of the VT targets, followed by endocardial and epicardial cryoballoon ablation of clinical VT. Subsequently, during LVAD implantation, dual cryoballoon ablation was applied around the surgical incision site to prevent VT associated with the surgical wound and the implanted device. At the 1-year follow-up, the patient had no recurrence of the original clinical VT and no new ventricular arrhythmias were observed.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted a case report in Non-ischemic dilated cardiomyopathy with recurrent ventricular tachycardia (n=1). Left ventricular assist device (LVAD) implantation combined with cryoballoon ablation was evaluated on Recurrence of clinical ventricular tachycardia or new ventricular arrhythmias. Left ventricular assist device implantation combined with cryoballoon ablation resulted in no recurrence of clinical ventricular tachycardia or new ventricular arrhythmias at 1-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: